Dynavax to Present at Upcoming Investment Conferences
EMERYVILLE, Calif., Sept. 27, 2021 /PRNewswire/ -- Dynavax Technologies (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, today announced that it will participate in the following investor conferences.
2021 Cantor Virtual Global Healthcare Conference
Guggenheim 2nd Annual Vaccine and Infectious Disease Conference
H.C. Wainwright 2nd Hepatitis B Virus (HBV) Virtual Conference
All the conferences are being held virtually. A live webcast of each of the presentations will be available and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at http://investors.dynavax.com/events-presentations.
Derek Cole, President
View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-upcoming-investment-conferences-301385981.html
SOURCE Dynavax Technologies
Company Codes: NASDAQ-SMALL:DVAX